Trials / Sponsors / Base Therapeutics (Shanghai) Co., Ltd.
Base Therapeutics (Shanghai) Co., Ltd.
Industry · 7 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer Gastric Cancer (GC), Colorectal Cancer | EARLY_Phase 1 | 2025-11-01 |
| Not Yet Recruiting | NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus Refractory Systemic Lupus Erythematosus | N/A | 2025-08-01 |
| Recruiting | Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia Relapsed/Refractory Acute Myeloid Leukemia | EARLY_Phase 1 | 2024-07-01 |
| Recruiting | Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia Relapsed/Refractory Acute Myeloid Leukemia | EARLY_Phase 1 | 2024-07-01 |
| Unknown | Safety and Efficacy of NK510 to Treat Gastric Cancer Gastric Cancer | EARLY_Phase 1 | 2023-11-01 |
| Recruiting | Safety and Efficacy of NK510 to Treat NSCLC NSCLC | EARLY_Phase 1 | 2023-07-01 |
| Unknown | Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma Osteosarcoma, Soft Tissue Sarcoma | EARLY_Phase 1 | 2022-09-01 |